Haemonetics (HAE) Ownership - Who Owns Haemonetics?

431 Followers

Haemonetics (HAE) Ownership Overview

1.39% Insiders

35.96% Mutual Funds

18.80% Other Institutional Investors

27.42% ETFs

16.43% Public Companies and

Individual Investors

The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 82.18% of the company’s stock is owned by Institutional Investors, 1.39% is owned by Insiders, and 16.43% is owned by Public Companies and Individual Investors.

The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 54.76% of the company’s stock is owned by Institutional Investors, 1.39% is owned by Insiders, and 27.42% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Nov 12, 2025	Mark Kroll	xxxxxxxxxxxxx	$98784

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$2726528
Mar 31, 2024	Hussman Strategic Advisors Inc	xxxxxxxxxxxxx	$591780
Mar 31, 2024	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$320745
Mar 31, 2024	Blackstone Inc.	xxxxxxxxxxxxx	$360704

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	5,146,177	Institution	11.07%	289,678,303
	4,266,318	Institution	9.18%	240,151,040
	3,753,193	Institution	8.08%	211,267,234
	3,627,137	Institution	7.81%	204,171,542
	957,861	Institution	2.06%	53,917,996
	950,260	Institution	2.04%	53,490,135
	862,690	Institution	1.86%	48,560,820
Ken Fisher	662,504	Institution	1.43%	37,292,350
	636,613	Institution	1.37%	35,834,946
	544,170	Institution	1.17%	30,631,329

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
3,753,193	Institution	8.08%	211,267,234
3,627,137	Institution	7.81%	204,171,542
950,260	Institution	2.04%	53,490,135
862,690	Institution	1.86%	48,560,820
636,613	Institution	1.37%	35,834,946
544,170	Institution	1.17%	30,631,329
530,682	Institution	1.14%	29,872,090
508,105	Institution	1.09%	28,601,230
363,531	Institution	0.78%	20,463,160
345,956	Institution	0.74%	19,473,863

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Mid-Cap ETF	1,569,639	Institution	3.38%	84,776,202
iShares S&P Mid-Cap ETF CDI	1,567,099	Institution	3.37%	121,152,424
Vanguard Total Stock Market ETF	1,487,983	Institution	3.20%	83,862,722
iShares Russell 2000 ETF	1,100,177	Institution	2.37%	59,420,560
Vanguard Small-Cap ETF	1,072,877	Institution	2.31%	60,467,348
Vanguard Extended Market ETF	519,371	Institution	1.12%	29,271,750
iShares Russell 2000 Growth ETF	386,923	Institution	0.83%	20,897,711
SPDR S&P Midcap 400 ETF Trust	351,232	Institution	0.76%	19,770,849
Vanguard Small Cap Value ETF	341,471	Institution	0.73%	19,245,306
Vanguard Small-Cap Growth ETF	299,426	Institution	0.64%	16,875,649

FAQ

Who Owns Haemonetics (HAE)?

According to the latest TipRanks data, approximately 18.80% of the company's stock is held by institutional investors, 1.39% is held by insiders, and 16.43% is held by retail investors.

What percentage of Haemonetics (HAE) stock is held by institutional investors?

According to the latest TipRanks data, approximately 18.80% of Haemonetics (HAE) stock is held by institutional investors.

What percentage of Haemonetics (HAE) stock is held by retail investors?

According to the latest TipRanks data, approximately 16.43% of Haemonetics (HAE) stock is held by retail investors.

Who owns the most shares of Haemonetics (HAE)?

iShares owns the most shares of Haemonetics (HAE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.